Tiffany Kary

Tiffany Kary is a journalist for Bloomberg who covers business and finance news. She has written about Altria Group Inc., a tobacco company that sells Marlboro cigarettes in the US. Recently, she reported on Altria's sale of 35 million AB InBev shares, which raised approximately $2.4 billion to fund its own share repurchases and reduce its stake in AB InBev from about 10% to 8.1%. This transaction is an opportunistic move by Altria to generate a substantial return on its investment after years of speculation about the sale of its stake in AB InBev.

64%

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

85%

Examples:

  • Altria expects to save money by spending less on dividends after the shares are repurchased
  • Altria sold 35 million AB InBev shares
  • The tobacco company announced a $2.4 billion increase to its existing $1 billion buyback program

Conflicts of Interest

50%

Examples:

  • Altria raised about $2.4 billion from the sale of Anheuser-Busch InBev SA shares
  • The fact that Altria’s selling some of the stake now, as competition heats up in cigarette alternatives, suggests it may also use some of the proceeds to develop its own products

Contradictions

100%

Examples:

No current examples available.

Deceptions

50%

Examples:

  • Altria raised about $2.4 billion from the sale of Anheuser-Busch InBev SA shares
  • The fact that Altria’s selling some of the stake now, as competition heats up in cigarette alternatives, suggests it may also use some of the proceeds to develop its own products

Recent Articles

Altria Group to Sell One-Fifth of Its Stake in Anheuser-Busch InBev for $2.4 Billion

Altria Group to Sell One-Fifth of Its Stake in Anheuser-Busch InBev for $2.4 Billion

Broke On: Thursday, 14 March 2024 Altria Group, a tobacco giant in the US, plans to sell one-fifth of its stake in AB InBev for $2.4 billion. The funds will be used for share buybacks and debt payment as AB InBev faces tougher regulations and competition from disposable vapes.